Premature coronary artery disease: An inferred cardiovascular variant or a South Asian genetic disorder?

Jeetesh V. Patel; Shridhar Dwivedi; Elizabeth A. Hughes; Gregory Y. H. Lip

doi:10.1160/TH08-05-0286

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2008; 99(06): 991-992
DOI: 10.1160/TH08-05-0286

Editorial Focus

Schattauer GmbH

Premature coronary artery disease: An inferred cardiovascular variant or a South Asian genetic disorder?

Jeetesh V. Patel

¹Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK

,

Shridhar Dwivedi

²Preventative Cardiology, University College of Medical Sciences, University of Delhi, Delhi, India

,

Elizabeth A. Hughes

¹Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK

,

Gregory Y. H. Lip

¹Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK

› Author Affiliations

Abstract

Full Text

References

References
1 Derry CW, Bourne DE, Sayed AR. et al. Variations in mortality of coloured, white and Asian population groups in the RSA, 1978–1982 Part VI. Ischaemic heart disease. South African Med J 1987; 72: 698-700.
2 Miller GJ, Beckles GLA, Maude GH. et al. Ethnicity and other characteristics predictive of coronary heart disease in a developing community: the principal results of the St James survey, Trinidad. Int J Epidemiol 1989; 18: 808-817.
3 Hughes K, Lun KC, Yeo PPB. Cardiovascular disease in Chinese, Malays, and Indians in Singapore. I. Differences in mortality. J Epidemiol Comm Health 1990; 44: 24-28.
4 Collins VR, Dowse GK, Cabealawa S. et al. High mortality from cardiovascular disease and analysis of risk factors in Indian and Melanesian Fijians. Int J Epidemiol 1996; 25: 59-69.
5 Tuomilehto J, Li N, Dowse G. et al. The prevalence of coronary heart disease in the multi-ethnic and high diabetes prevalence population of Mauritius. J Intern Med 1993; 233: 187-194.
6 Anand SS, Yusuf S, Vuksan V. et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000; 356: 279-284.
7 Mathers CD, Stein C, Ma Fat M. et al. The Global Burden of Disease 2000 Study (version 2): Methods and Results. Discussion Paper 50. Geneva: Global Program on Evidence for Health Policy, World Health Organization; 2002. http://www.who.int/infobase IBRef: 19998.
8 Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97: 596-601.
9 Yusuf S, Reddy S, Ounpuu S. et al. Global burden of cardiovascular diseases, part II: variations in cardiovascular diseases by specific ethnic groups and geographic and prevention strategies. Circulation 2001; 104: 2855-2864.
10 Joshi P, Islam S, Pais P. et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. J Am Med Assoc 2007; 297: 286-294.
11 Rastogi SK. Myocardial infarction in young adults. Indian Heart J 1968; 20: 289-295.
12 Antani JA. A comparative clinical study of ischemic heart disease in the young and the elderly. Indian Heart J 1973; 25: 157-160.
13 Dwivedi S, Somani PN, Gode KD. Risk factors in patients of coronary artery disease. Ind J Preventive and Social Medicine 1975; 6: 139-145.
14 Iribarren C, Go AS, Husson G. et al. Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts?. J Am Coll Cardiol 2006; 48: 1800-1807.
15 Soltesz P, Veres K, Laczik R. et al. Evaluation of antibodies to oxidized low-density lipoprotein and assessment of C-reactive protein in acute coronary syndrome and stable coronary artery disease. Thromb Haemost 2007; 98: 413-419.
16 Vokó Z, Bereczky Z, Katona E. et al. Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis. Thromb Haemost 2007; 97: 458-463.
17 Marcucci R, Paniccia R, Antonucci E. et al. Residual platelet reactivity is an independent predictor of myocardial injury in acute myocardial infarction patients on antiaggregant therapy. Thromb Haemost 2007; 98: 844-851.
18 Aukrust P, Yndestad A, Smith C. et al. Chemokines in cardiovascular risk prediction. Thromb Haemost 2007; 97: 748-754.
19 Maitra A, Shanker J, Dash D. et al. Polymorphisms in the IL6 gene in Asian Indian families with premature coronary artery disease – The Indian Atherosclerosis Research Study. Thromb Haemost 2008; 99: 944-950.
20 Best LG, North KE, Tracy RP. et al. Genetic determination of acute phase reactant levels: the strong heart study. Hum Hered 2004; 58: 112.
21 Haverkate F, Thompson SG, Pyke SD. et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997; 349: 462-466.
22 Ridker PM, Cushman M, Stampfer MJ. et al. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979.
23 Chambers JC, Eda S, Bassett P. et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 2001; 104: 145-150.
24 Chandalia M, Cabo-Chan Jr AV, Devaraj S. et al. Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States. J Clin Endocrinol Metab 2003; 88: 3773-3776.
25 Vasan RS. Biomarkers of cardiovascular disease. Circulation 2006; 113: 2335-2362.